Aperio Group’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $25K | Buy |
+298
| New | +$25K | ﹤0.01% | 2423 |
|
|
2020
Q3 | – | Sell |
-122
| Closed | -$11K | – | 2400 |
|
|
2020
Q2 | $11K | Buy |
+122
| New | +$11K | ﹤0.01% | 2329 |
|
|
2019
Q4 | – | Sell |
-86
| Closed | -$29K | – | 2351 |
|
|
2019
Q3 | $29K | Sell |
86
-32
| -27% | -$10.8K | ﹤0.01% | 2295 |
|
|
2019
Q2 | $108K | Buy |
118
+33
| +39% | +$30.2K | ﹤0.01% | 2368 |
|
|
2019
Q1 | $135K | Sell |
85
-8
| -9% | -$12.7K | ﹤0.01% | 2215 |
|
|
2018
Q4 | $173K | Sell |
93
-13
| -12% | -$24.2K | ﹤0.01% | 2165 |
|
|
2018
Q3 | $251K | Sell |
106
-12
| -10% | -$28.4K | ﹤0.01% | 2098 |
|
|
2018
Q2 | $406K | Sell |
118
-13
| -10% | -$44.7K | ﹤0.01% | 1847 |
|
|
2018
Q1 | $372K | Buy |
131
+20
| +18% | +$56.8K | ﹤0.01% | 1840 |
|
|
2017
Q4 | $285K | Sell |
111
-4
| -3% | -$10.3K | ﹤0.01% | 1967 |
|
|
2017
Q3 | $325K | Buy |
115
+7
| +6% | +$19.8K | ﹤0.01% | 1878 |
|
|
2017
Q2 | $256K | Buy |
108
+3
| +3% | +$7.11K | ﹤0.01% | 1979 |
|
|
2017
Q1 | $265K | Buy |
+105
| New | +$265K | ﹤0.01% | 1885 |
|
|
2016
Q4 | – | Sell |
-105
| Closed | -$262K | – | 2142 |
|
|
2016
Q3 | $262K | Buy |
+105
| New | +$262K | ﹤0.01% | 1791 |
|
|
2016
Q2 | – | Sell |
-77
| Closed | -$246K | – | 2045 |
|
|
2016
Q1 | $246K | Sell |
77
-19
| -20% | -$60.7K | ﹤0.01% | 1766 |
|
|
2015
Q4 | $495K | Buy |
96
+26
| +37% | +$134K | ﹤0.01% | 1343 |
|
|
2015
Q3 | $221K | Buy |
70
+7
| +11% | +$22.1K | ﹤0.01% | 1715 |
|
|
2015
Q2 | $252K | Buy |
+63
| New | +$252K | ﹤0.01% | 1733 |
|
|
2015
Q1 | – | Sell |
-53
| Closed | -$261K | – | 2006 |
|
|
2014
Q4 | $261K | Buy |
+53
| New | +$261K | ﹤0.01% | 1597 |
|